Related Experiment Videos
Trabeculectomy with antiproliferative agents in uveitic glaucoma
Elizenda M Ceballos1, Allen D Beck, Michael J Lynn
1Department of Ophthalmology, Emory University School of Medicine and Department of Biostatistics, Rollins School of Public Health of Emory University, Atlanta, Georgia 30322, USA.
Journal of Glaucoma
|July 26, 2002
Summary
Trabeculectomy with antiproliferative agents shows good outcomes for uveitic glaucoma patients. Male gender is a risk factor for failure, and cataract surgery can complicate intraocular pressure control.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Surgical Outcomes
Background:
- Uveitic glaucoma presents unique challenges in intraocular pressure (IOP) management.
- Trabeculectomy is a common surgical intervention for glaucoma, but its efficacy in uveitic cases requires specific evaluation.
Purpose of the Study:
- To assess the effectiveness and outcomes of trabeculectomy combined with antiproliferative agents in patients diagnosed with uveitic glaucoma.
Main Methods:
- A retrospective review analyzed data from 44 eyes of patients with uveitic glaucoma who underwent trabeculectomy with mitomycin C or 5-fluorouracil.
- Success was defined by IOP thresholds (≤21 mm Hg) with or without medications, and failure by elevated IOP, vision loss, or reoperation.
Main Results:
- The cumulative success rate for trabeculectomy was 78% at 1 year and 62% at 2 years.
- Female patients (71%) had significantly higher success rates than males (39%) at 2 years (P=0.02).
- Cataract development or progression occurred in 51.6% of phakic patients, with 25% losing IOP control after subsequent cataract surgery.
Conclusions:
- Trabeculectomy with antiproliferative agents offers favorable outcomes for uveitic glaucoma.
- Male gender emerged as a significant predictor of surgical failure.
- Managing cataracts in patients with existing filtering blebs presents a challenge, balancing visual improvement against IOP control.